Don’t let the high cost of brand epinephrine auto-injectors disrupt your access to life-saving anaphylaxis rescue therapy. We help eligible patients access Auvi-Q (epinephrine auto-injector) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
The Auvi-Q Prescription Assistance Program is a manufacturer-sponsored initiative that provides Auvi-Q at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for severe allergy patients who are uninsured or underinsured.
Navigating the program on your own means dealing with eligibility verification, allergist/primary care coordination, prior-authorization documentation, and renewal deadlines. Auvi-Q’s manufacturer offers a ‘Direct Delivery’ program that ships Auvi-Q at low or no cost to many commercially insured patients.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing refill coordination and annual re-certification.
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$680 | Save ~$610/2-pack |
| CVS Pharmacy | ~$700 | Save ~$630/2-pack |
| Walmart | ~$620 | Save ~$550/2-pack |
| Costco | ~$610 | Save ~$540/2-pack |
Mfr Direct Delivery (commercially insured) | ~$35 | Manufacturer program |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
1 Medications
2 Medications
3 Medications
4+ Medications
The Patient Assistance Program is free to apply for and provides Auvi-Q at no medication cost if approved. Our $69.95/month service covers full advocacy. The manufacturer’s Direct Delivery program may also provide Auvi-Q at $35 or less to commercially insured patients meeting income criteria.
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Auvi-Q:
Still $600–$700 per 2-pack per month even with the best discount
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Auvi-Q assistance.
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Auvi-Q is an epinephrine auto-injector with built-in voice instructions that guide the user step-by-step through the injection process. It is also the only auto-injector with a 0.1 mg dose for infants and small children (7.5–15 kg) — filling a gap left by other auto-injectors that start at 0.15 mg. Compact, portable size and intuitive design make Auvi-Q particularly useful for first-time users, untrained bystanders, and pediatric patients.
How Auvi-Q Works:
Anaphylaxis is a severe, life-threatening allergic reaction that can cause fatal cardiovascular collapse, airway constriction, or swelling within minutes. Epinephrine reverses these dangerous symptoms by opening the airways, reducing swelling, and increasing cardiac output. Auvi-Q is a spring-loaded, single-dose auto-injector that delivers this medication via an injection into the outer thigh. Notably, the device features unique voice-prompt guidance that helps first-time users and bystanders administer the correct dose based on the patient’s age and weight.
Form and use:
To use Auvi-Q during suspected anaphylaxis, remove the red safety guard, press the black end firmly against the outer thigh for two seconds, and follow the voice instructions. It can be injected through clothing, and the device will signal when the dose delivery is complete. After administration, emergency medical services must be called immediately for further required care. Because symptoms can persist or return, patients at risk should always carry two auto-injectors at all times.
Generic availability:
There is currently no generic version of Auvi-Q available in the U.S. because its unique voice-prompt design is patent-protected. However, other FDA-approved epinephrine options exist, including EpiPen, various generic auto-injectors, prefilled syringes, and a needle-free nasal spray. If a patient does not specifically need the voice-guided feature or the specialized infant dose, these generic alternatives are often a more cost-effective choice.
Warnings:
There are no absolute reasons to withhold epinephrine during an anaphylactic emergency, as the risk of not treating the reaction far outweighs any potential drug risks. Common side effects include a racing heart, anxiety, tremors, headaches, and sweating. While serious complications like arrhythmias, stroke, or heart attack are rare, the medication should be used cautiously in older individuals with heart disease. Additionally, care should be taken to avoid accidental injection into fingers or toes, which can cause localized blood vessel constriction.
Auvi-Q retail costs approximately $600–$700 per 2-pack. The manufacturer’s Direct Delivery program provides Auvi-Q at $35 or less to many commercially insured patients meeting income criteria — bypassing pharmacies. Through AffordMyPrescriptions, qualifying patients receive Auvi-Q at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
Both are epinephrine auto-injectors. Auvi-Q is compact (smaller than EpiPen), has voice-prompt guidance for use, and has a 0.1 mg dose option for infants and small children (7.5–15 kg) — uniquely useful in pediatric anaphylaxis where existing auto-injector doses (0.15 mg, 0.3 mg) may be larger than needed. EpiPen and generic auto-injectors don’t have voice prompts or the 0.1 mg option, but generics are cheaper. Effectiveness for anaphylaxis is similar at equivalent doses.
Auvi-Q has the 0.1 mg dose specifically for infants and small children 7.5–15 kg — making it uniquely suitable for this age range. Other auto-injectors don’t have a dose lower than 0.15 mg, which may be more epinephrine than ideal for very small children. Discuss with your child’s allergist; many recommend Auvi-Q 0.1 mg for infants at anaphylaxis risk.
Auvi-Q’s manufacturer (Kaléo) operates a Direct Delivery program that ships Auvi-Q directly to commercially insured patients at $35 or less per 2-pack, often free for those meeting income criteria — bypassing pharmacy retail. This can be more affordable than even generic auto-injectors at retail. Eligibility requires commercial insurance (not Medicare/Medicaid) and meeting income criteria. We can help you enroll.
Store at room temperature (68–77°F / 20–25°C); avoid extreme heat or cold. Do not refrigerate. Check expiration date regularly. Periodically inspect the inspection window — solution should be clear and colorless; do not use if discolored or particulate. Replace expired or damaged devices.
Yes — current guidelines recommend carrying TWO auto-injectors at all times because some anaphylactic reactions require a second dose. The second dose may be needed if symptoms persist or recur within minutes of the first dose, or if symptoms worsen during transport. Always call 911 after using an auto-injector.
If denied, we explore alternatives — the manufacturer’s Direct Delivery program (for commercially insured), switching to a generic epinephrine auto-injector (much cheaper), Neffy nasal spray as a needle-free alternative, or independent foundations such as Food Allergy Research & Education (FARE), Asthma and Allergy Foundation of America, PAN Foundation, or HealthWell Foundation. If we cannot find a path, you won’t be charged our service fee.If denied, we explore alternatives — switching to generic tetrabenazine (much cheaper, but with more side effects), Ingrezza for tardive dyskinesia (with its own PAP), the manufacturer’s copay program for commercially insured patients, or independent foundations such as the Huntington’s Disease Society of America, PAN Foundation, or HealthWell Foundation. If we cannot find a path, you won’t be charged our service fee.
If you are struggling with the high cost of Auvi-Q, our team may be able to help you access assistance programs — or guide you to the manufacturer’s Direct Delivery program or a generic auto-injector. Check your eligibility today.
Start free by filling out a simple online form.
Our specialist will contact you for a quick welcome call.
Our team handles everything, so you can focus on your health.